Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
LGND Analyst Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LGND Stock 12 Month Forecast
Average Price Target
$150.40
▲(13.32%Upside)
| Highest Price Target$162.00 | Average Price Target$150.40 | Lowest Price Target$135.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$143
Hold
7.75%
Upside
Reiterated
07/18/25
Ligand Pharma's overall stock score is primarily influenced by its mixed financial performance, with strengths in technical analysis and positive earnings call sentiment. The recent corporate event also adds value; however, concerns about valuation and operational efficiency temper the overall score.
Craig-Hallum
―
Buy
―
Reiterated
08/01/25
Oppenheimer
$145→$162
Buy
22.06%
Upside
Reiterated
07/30/25
Stifel Nicolaus
$143
Buy
7.75%
Upside
Reiterated
07/17/25
Benchmark Co.
$135
Buy
1.72%
Upside
Reiterated
05/09/25
H.C. Wainwright
$157
Buy
18.29%
Upside
Reiterated
05/08/25
Barclays
$160
Buy
20.55%
Upside
Reiterated
03/10/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$143
Hold
7.75%
Upside
Reiterated
07/18/25
Ligand Pharma's overall stock score is primarily influenced by its mixed financial performance, with strengths in technical analysis and positive earnings call sentiment. The recent corporate event also adds value; however, concerns about valuation and operational efficiency temper the overall score.
Craig-Hallum
―
Buy
―
Reiterated
08/01/25
Oppenheimer
$145→$162
Buy
22.06%
Upside
Reiterated
07/30/25
Stifel Nicolaus
$143
Buy
7.75%
Upside
Reiterated
07/17/25
Benchmark Co.
$135
Buy
1.72%
Upside
Reiterated
05/09/25
H.C. Wainwright
$157
Buy
18.29%
Upside
Reiterated
05/08/25
Barclays
$160
Buy
20.55%
Upside
Reiterated
03/10/25
Best Analysts Covering Ligand Pharma
1 Month
xxx
Success Rate
10/14 ratings generated profit
Average Return
+1.39%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +1.39% per trade.
3 Months
xxx
Success Rate
22/35 ratings generated profit
Average Return
+7.51%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.86% of your transactions generating a profit, with an average return of +7.51% per trade.
1 Year
Success Rate
12/14 ratings generated profit
Average Return
+28.47%
reiterated a buy rating 3 months ago
Copying Robert Wasserman's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +28.47% per trade.
2 Years
xxx
Success Rate
12/14 ratings generated profit
Average Return
+34.36%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +34.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LGND Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
1
1
1
0
Buy
10
8
8
10
6
Hold
0
1
2
8
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
10
11
19
13
Each month's total comprises the sum of three months' worth of ratings.
LGND Financial Forecast
LGND Stock Forecast FAQ
What is LGND’s average 12-month price target, according to analysts?
Based on analyst ratings, Ligand Pharma’s 12-month average price target is 150.40.
What is LGND’s upside potential, based on the analysts’ average price target?
Ligand Pharma has 13.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LGND a Buy, Sell or Hold?
Ligand Pharma has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is Ligand Pharma’s price target?
The average price target for Ligand Pharma is 150.40. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $162.00 ,the lowest forecast is $135.00. The average price target represents 13.32% Increase from the current price of $132.72.
The highest analyst price target is $162.00 ,the lowest forecast is $135.00. The average price target represents 13.32% Increase from the current price of $132.72.
What do analysts say about Ligand Pharma?
Ligand Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of LGND?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.